Table 1 Clinical features of patients with fibrostenosing Crohn’s disease (n=29)
From: The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis
Characteristics and parameters | n | Median (range) |
|---|---|---|
Age, years | 35.8 (23 to 61) | |
First attack | 6 | |
Intestinal location | ||
Small bowel and colon | 15 | |
Small bowel only | 9 | |
Colon only | 5 | |
Duration of disease, months | 81.2 (7 to 196) | |
Number of recurrences | 4 (0 to 9) | |
CDAI | 223 (155 to 426) | |
Treatment | ||
Mesalazine | 13 | |
Topical steroids | 3 | |
Antibiotics | 9 | |
Azathioprine/6-MP/methotrexate | 14 |